TrialCancer immunology, immunotherapy : CII2012

Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial.

Eva Ellebaek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.